The implementation of targeted treatment requires a multi-step process:
1. Identification of Target Groups: This involves the use of epidemiological studies to identify population subsets that are at higher risk for certain diseases or are more likely to benefit from specific treatments. 2. Development of Targeted Therapies: This step involves the creation of therapies that are specifically designed to address the unique characteristics of the identified target groups. 3. Testing and Validation: Clinical trials are conducted to test the efficacy and safety of the targeted therapies. 4. Deployment and Monitoring: Once validated, the therapies are deployed, and their impact is continuously monitored to ensure effectiveness and safety.
